-
Mashup Score: 0When Patient Care Requires ‘Negotiated Reliance’ - 13 day(s) ago
Difficult-to-help patients can present clinicians with interpersonal challenges.
Source: www.empr.comCategories: General Medicine NewsTweet
-
Mashup Score: 0FDA Alert Warns of Possible Hyperthermia With Antinausea Patch - 14 day(s) ago
Through August 16, 2024, the Agency has identified 13 cases worldwide of hyperthermia associated with scopolamine patches.
Source: www.empr.comCategories: General Medicine NewsTweet-
The time from patch application to hyperthermia onset was typically less than 72 hours. https://t.co/4JQGZDQoqx https://t.co/ez1gaspBkU
-
-
Mashup Score: 0Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval - 15 day(s) ago
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Source: www.empr.comCategories: General Medicine NewsTweet-
Yeztugo demonstrated superiority over Truvada in reducing the risk of incident HIV-1 infections. https://t.co/WgZSUlTEiq
-
-
Mashup Score: 0FDA Alert Warns of Possible Hyperthermia With Antinausea Patch - 17 day(s) ago
Through August 16, 2024, the Agency has identified 13 cases worldwide of hyperthermia associated with scopolamine patches.
Source: www.empr.comCategories: General Medicine NewsTweet-
The time from patch application to hyperthermia onset was typically less than 72 hours. https://t.co/4JQGZDQoqx https://t.co/ez1gaspBkU
-
-
Mashup Score: 1RFK Jr’s Actions Leave Vaccine Program “Critically Weakened", Say Former ACIP Members - 18 day(s) ago
The former ACIP members are “deeply concerned that these destabilizing decisions may roll back the achievements of US immunization policy.”
Source: www.empr.comCategories: General Medicine NewsTweet-
The former members expressed their concerns regarding their abrupt dismissal, the lack of vetting for the new ACIP members, and workforce reductions which “have left the US vaccine program critically weakened.” https://t.co/1mAacpUTyB https://t.co/Or2XVk8LJp
-
-
Mashup Score: 0
Previously, the vaccine had only been indicated for individuals 60 years of age and older.
Source: www.empr.comCategories: General Medicine NewsTweet-
Respiratory syncytial virus vaccine now approved for those aged 18 through 59 years. https://t.co/5zaJGIkDj2 https://t.co/OUiGEPMjRP
-
-
Mashup Score: 0
Pediatricians should provide their patients with their contraceptive of choice, if no medical contraindications exist.
Source: www.empr.comCategories: General Medicine NewsTweet-
The new updated guidance discusses the need for clinicians to become familiar with consent laws in their jurisdiction. https://t.co/pJ2ho9wmsr https://t.co/6Ny5jDXfJn
-
-
Mashup Score: 0Zusduri Approved for Recurrent Low-Grade Intermediate-Risk NMIBC - 22 day(s) ago
The approval was based on the single-arm, phase 3 ENVISION trial.
Source: www.empr.comCategories: General Medicine NewsTweet-
Zusduri gets green light for non-muscle invasive bladder cancer. https://t.co/F3hioJA6GM https://t.co/IkaJYf28Tb
-
-
Mashup Score: 1RFK Jr Selects 8 New Members for CDC’s Vaccine Advisory Panel - 23 day(s) ago
The announcement, which was made on X, lists the 8 new members and their credentials.
Source: www.empr.comCategories: General Medicine NewsTweet-
The American Medical Association said the organization is “deeply concerned” about Kennedy’s choices and that the selections were made “without transparency and proper vetting”. https://t.co/cfgQETd6Cl https://t.co/JCLsMCos5L
-
-
Mashup Score: 0
Mavyret is a fixed dose combination of the direct-acting antiviral agents, glecaprevir, a HCV NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor.
Source: www.empr.comCategories: General Medicine NewsTweet-
Hep C treatment gains expanded approval. https://t.co/c8AWgxUeFx https://t.co/bkuxR9QfhV
-
Feature: What happens when healthcare providers feel competition with their patients? https://t.co/wlN481hUPl